TEAM Stock Analysis: Atlassian | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 26.463m USD | 12M Return: -40.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 341M
EPS Trend: 80.9%
Qual. Beats: 4
Rev. Trend: 99.9%
Qual. Beats: 3
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Atlassian Corporation is a collaboration software provider that helps organizations connect teams and improve productivity at scale. Its product suite spans project management (Jira), team collaboration and knowledge sharing (Confluence), asynchronous video communication (Loom), IT and HR service management (Jira Service Management), and AI-powered workflows (Rovo). The company also offers developer-focused tools such as Bitbucket, Compass, and Jira Align, as well as productivity and security applications including Trello and Guard.
The company was founded in 2002 and is headquartered in Sydney, Australia, while trading on the NASDAQ as a U.S.-listed ADR. It generates revenue primarily through a subscription-based, seat-licensed software model that targets both large enterprises and smaller teams, operating within the Application Software sub-industry of the broader Information Technology sector. A notable strategic partnership with Mattermost supports the development of a sovereign, self-hosted successor to Confluence for defense, intelligence, and critical infrastructure clients, reflecting the firms expansion into regulated and security-sensitive markets.
- Cloud subscription ARR growth fuels top-line expansion
- Rovo AI adoption drives enterprise seat expansion
- Microsoft Azure DevOps competition pressures Jira share
| Net Income: -216.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA -3.63 > 1.0 |
| NWC/Revenue: -15.98% < 20% (prev 15.81%; Δ -31.79% < -1%) |
| CFO/TA 0.22 > 3% & CFO 1.25b > Net Income -216.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.70 > 1.5 & < 3 |
| Outstanding Shares: last quarter (261.0m) vs 12m ago -0.65% < -2% |
| Gross Margin: 83.85% > 18% (prev 82.31%; Δ 1.55% > 0.5%) |
| Asset Turnover: 107.3% > 50% (prev 84.34%; Δ 22.99% > 0%) |
| Interest Coverage Ratio: -3.32 > 6 (EBIT TTM -144.0m / Interest Expense TTM 43.4m) |
| A: -0.18 (Total Current Assets 2.33b - Total Current Liabilities 3.32b) / Total Assets 5.65b |
| B: -1.04 (Retained Earnings -5.90b / Total Assets 5.65b) |
| C: -0.02 (EBIT TTM -144.0m / Avg Total Assets 5.77b) |
| D: 0.18 (Book Value of Equity 879.0m / Total Liabilities 4.77b) |
| Altman-Z'' = -4.52 = D |
| DSRI: 1.13 (Receivables 907.4m/642.0m, Revenue 6.19b/4.96b) |
| GMI: 0.98 (GM 82.31% / 83.85%) |
| AQI: 1.76 (AQ_t 0.55 / AQ_t-1 0.31) |
| SGI: 1.25 (Revenue 6.19b / 4.96b) |
| TATA: -0.26 (NI -216.8m - CFO 1.25b) / TA 5.65b) |
| Beneish M = -2.34 (Cap -4..+1) = BBB |
As of August 05, 2026, the stock is trading at USD 110.31 with a total of 4,581,429 shares traded. Over the past week, the price has changed by +10.33%, over one month by +29.02%, over three months by +18.41% and over the past year by -40.59%.
Current recommended Stop Loss: 101.80 (which is 7.7% or 1.2 ATR below the current price).
Atlassian has received a consensus analysts rating of 4.36. Therefore, it is recommended to buy TEAM.
- StrongBuy: 19
- Buy: 7
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 139.7 | 26.6% |
P/E Forward = 15.2905
P/S = 4.275
P/B = 28.8634
P/EG = 0.7644
Revenue TTM = 6.19b USD
EBIT TTM = -144.0m USD
EBITDA TTM = -19.6m USD
Long Term Debt = 989.1m USD (from longTermDebt, last quarter)
Short Term Debt = 48.2m USD (from shortTermDebt, last quarter)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter) + Leases 253.9m
Net Debt = 360.6m USD (calculated: Debt 1.50b - CCE 1.14b)
Enterprise Value = 26.8b USD (26.5b + Debt 1.50b - CCE 1.14b)
Interest Coverage Ratio = -3.32 (Ebit TTM -144.0m / Interest Expense TTM 43.4m)
EV/FCF = 22.27x (Enterprise Value 26.8b / FCF TTM 1.20b)
FCF Yield = 4.49% (FCF TTM 1.20b / Enterprise Value 26.8b)
FCF Margin = 19.46% (FCF TTM 1.20b / Revenue TTM 6.19b)
Net Margin = -3.50% (Net Income TTM -216.8m / Revenue TTM 6.19b)
Gross Margin = 83.85% ((Revenue TTM 6.19b - Cost of Revenue TTM 999.5m) / Revenue TTM)
Gross Margin QoQ = 84.92% (prev 85.02%)
Tobins Q-Ratio = 4.75 (Enterprise Value 26.8b / Total Assets 5.65b)
Interest Expense / Debt = 2.90% (Interest Expense 43.4m / Debt 1.50b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -113.8m (EBIT -144.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.70 (Total Current Assets 2.33b / Total Current Liabilities 3.32b)
Debt / Equity = 1.70 (Debt 1.50b / totalStockholderEquity, last quarter 879.0m)
Debt / EBITDA = -18.44 (negative EBITDA) (Net Debt 360.6m / EBITDA -19.6m)
Debt / FCF = 0.30 (Net Debt 360.6m / FCF TTM 1.20b)
Total Stockholder Equity = 1.30b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.76% (Net Income -216.8m / Total Assets 5.65b)
RoE = -16.70% (Net Income TTM -216.8m / Total Stockholder Equity 1.30b)
RoCE = -6.30% (EBIT -144.0m / Capital Employed (Equity 1.30b + L.T.Debt 989.1m))
RoIC = -5.51% (negative operating profit) (NOPAT -113.8m / Invested Capital 2.07b)
WACC = 10.83% (E(26.5b)/V(28.0b) * Re(11.31%) + D(1.50b)/V(28.0b) * Rd(2.90%) * (1-Tc(0.21)))
Discount Rate = 11.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 66.64 | Cagr: 0.41%
[DCF] Terminal Value 64.45% ; FCFF base≈1.31b ; Y1≈1.15b ; Y5≈928.1m
[DCF] Fair Price = 64.16 (EV 10.6b - Net Debt 360.6m = Equity 10.2b / Shares 159.6m; r=10.83% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 80.85 | EPS CAGR: 19.09% | SUE: 4.0 | # QB: 4
Revenue Correlation: 99.86 | Revenue CAGR: 21.74% | SUE: 3.06 | # QB: 3
EPS current Quarter (2026-09-30): EPS=1.26 | Chg30d=-2.73% | Revisions=-17% | Analysts=26
EPS current Year (2026-06-30): EPS=5.51 | Chg30d=+0.03% | Revisions=+0% | GrowthEPS=+49.6% | GrowthRev=+24.3%
EPS next Year (2027-06-30): EPS=6.10 | Chg30d=-1.90% | Revisions=+0% | GrowthEPS=+10.7% | GrowthRev=+13.4%
[Analyst] Revisions Ratio: -8% (up=4, down=5)